Economy

Seattle Genetics, Inc. (NASDAQ:SGEN) EVP Sells $397448.19 in Stock

Us Savings Bank De has invested 0% of its portfolio in Seattle Genetics, Inc.

11/29/2016 - Seattle Genetics, Inc. was downgraded to "equal-weight" by analysts at Barclays. The rating was maintained by H.C. Wainwright on Monday, June 19 with "Buy".

Seattle Genetics, Inc. has a 1-year low of $45.31 and a 1-year high of $75.36. (NASDAQ:SGEN) was up +1.22% during the last trading session, with a day high of 53.81. Bank of America Corp lowered shares of Seattle Genetics from a "neutral" rating to an "underperform" rating in a research report on Friday, February 10th. They issued an "outperform" rating and a $58.00 price objective on the stock. The rating was maintained by Oppenheimer on Monday, June 26 with "Hold".

12/29/2016 - Seattle Genetics, Inc. had its "neutral" rating reiterated by analysts at Cantor Fitzgerald. The firm's market capitalization is $7.69 billion. The rating was maintained by Leerink Swann on Friday, August 14 with "Outperform".

J.P. Morgan maintained Seattle Genetics, Inc.

Driehaus Capital Management Llc increased Patrick Industries Inc (PATK) stake by 38.46% reported in 2016Q4 SEC filing. Ghost Tree Capital, LLC now controls 300,000 shares valued at $15,522,000. Stock rose 8.65% over the trailing 6 months. Ltd. now owns 15,613 shares of the biotechnology company's stock worth $981,000 after buying an additional 191 shares during the period. It also reduced Yandex Nv (NASDAQ:YNDX) stake by 921,567 shares and now owns 631,489 shares. Credicorp Ltd (NYSE:BAP) was raised too.

SGEN has been the subject of a number of recent research reports. Next quarter's EPS is forecasted to be $-0.44 and the next full year EPS is anticipated to be $-1.13. Rhumbline Advisers invested in 0% or 20,291 shares. The biotechnology company reported ($0.42) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.41) by $0.01. Three investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the company. Therefore 100% are positive. On Thursday, January 21 the stock rating was initiated by Credit Suisse with "Outperform". Argus Research maintained General Electric Company (NYSE:GE) on Wednesday, December 23 with "Buy" rating. The firm has "Buy" rating given on Wednesday, August 17 by CL King. The stock has "Outperform" rating by CLSA on Friday, May 26. William Blair maintained the shares of SGEN in report on Tuesday, August 25 with "Buy" rating. The firm has "Neutral" rating given on Thursday, March 31 by CL King. They now have a Dollars 70 price target on the stock. The stock of 58.com Inc (ADR) (NYSE:WUBA) earned "Buy" rating by HSBC on Tuesday, December 15. 15,568 are held by Comerica National Bank.

Since March 31, 2017, it had 0 buys, and 5 sales for $3.74 million activity. On Wednesday, April 5 the insider SIEGALL CLAY B sold $911,111.

On Monday, August 7th, Darren S. Cline sold 6,000 shares of Seattle Genetics stock.

Investors sentiment decreased to 1.27 in 2016 Q4. Its up 0.20, from 1 in 2016Q3.

On the close of 09/18/2017 Seattle Genetics, Inc. 60 funds opened positions while 64 raised stakes. Cantor Fitzgerald maintained Seattle Genetics, Inc. First Manhattan Co. now owns 3,150 shares of the biotechnology company's stock valued at $162,000 after purchasing an additional 750 shares in the last quarter. Nordea Invest Mngmt holds 2,762 shares or 0% of its portfolio. 50,000 are owned by Pointstate Capital Ltd Partnership. Moreover, Massachusetts Fincl Ma has 0% invested in Patrick Industries, Inc. Fifth Third Fincl Bank holds 134 shares or 0% of its portfolio. Daiwa Securities Group Inc. increased its stake in shares of Seattle Genetics by 562.5% during the first quarter. (NASDAQ:SGEN) now have an ABR of 2.46.which is marked on a basic 1 to 5 scale, where 1 stands for a Strong Buy and 5 represents Strong Sell. Pnc Financial Svcs Gru accumulated 3,265 shares.

06/20/2017 - Seattle Genetics, Inc. had its "overweight" rating reiterated by analysts at Morgan Stanley. (NASDAQ:SGEN) for 199,807 shares. The Company is involved in the development and sale of pharmaceutical products on its own behalf or in collaboration with others. SGEN's SI was 11.62M shares in September as released by FINRA.

Seattle Genetics (NASDAQ:SGEN) last announced its quarterly earnings data on Thursday, July 27th. The stock of Seattle Genetics, Inc. The stock increased 1.22% or $0.65 on September 15, reaching $53.79. Ltd. lifted its holdings in Seattle Genetics by 1.2% during the first quarter. It has outperformed by 20.42% the S&P500. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Seattle Genetics Inc. and related companies with MarketBeat.com's FREE daily email newsletter.



Like this

loading...
loading...

Latest


21 September 2017
Devon Energy Corporation (DVN) Receives $44.83 Average PT from Brokerages
The British Columbia - Canada-based British Columbia Invest Mngmt Corp has invested 0.04% in Wynn Resorts, Limited (NASDAQ:WYNN). On average, equities research analysts expect that Devon Energy Corporation will post $1.73 EPS for the current fiscal year.

21 September 2017
Man sets himself on fire outside NZ parliament in Wellington
Parliamentary Services said Parliament's forecourt and lawn hade been locked down and were being treated as a crime scene. In a statement, police said paramedics were treating the man now , who was in a critical condition.

21 September 2017
Singapore Grand Prix to remain on F1 calendar until 2021
Organisers project that another 100,000 may visit this year's race. Calvin Harris, Ariana Grande and Seal are on the bill this year. The 2016 edition attracted about 219,000 spectators.

21 September 2017
Canaccord Genuity Reaffirms "Hold" Rating for Esterline Technologies Co. (ESL)
Zurcher Kantonalbank Zurich Cantonalbank raised its stake in Esterline Technologies Corporation by 11.3% during the 2nd quarter. Esterline Technologies Corporation presently has an average rating of "Hold" and an average target price of $94.00.

21 September 2017
Stock is up at $33.83 (STLD) Steel Dynamics Provides Third Quarter…
A few investment analysts have issued ratings on the stock. (NDAQ: STLD ) from Neutral to Buy in a report released on 6/19/2017. Seven investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company's stock.

21 September 2017
Celldex Therapeutics, Inc. (CLDX) Receives $8.08 Consensus Target Price from Analysts
Raymond James Financial Services Advisors boosted its stake in stocks of Celldex Therapeutics by 26.2% through out the 1st period. Zacks Investment Research lowered Celldex Therapeutics from a "buy" rating to a "sell" rating in a report on Monday, July 17th.

21 September 2017
Redskins' Terrelle Pryor warns Rams defender to 'not take out knees'
Pryor was running across the field when Davis took the Washington wideout down with a low hit to the knees. As Pryor said, it wasn't a dirty play, but tackles of those nature can be terrifying for a receiver.

21 September 2017
AstraZeneca plc (AZN) Given "Buy" Rating at Deutsche Bank AG
The utilities provider reported $0.65 earnings per share for the quarter, missing the consensus estimate of $0.67 by ($0.02). Next Financial Group, Inc added to its stake by buying 115 shares an increase of 1.8% from 03/31/2017 to 06/30/2017.

21 September 2017
Kirsten Dunst Accidentally Got Stoned On The Set Of Her New Movie
I was like what the f**k. "I was like crying, laughing, eating a peanut butter sandwich", she later continued. So, when you see Dunst smoking it up in Woodshock , just know that she's not smoking actual marijuana.

21 September 2017
Retail sales in August 'blow forecasts out of the water'
The narrower measure of inflation used in retail sales data rose to an annual rate of 3.2 percent in August, up from 2.7 percent. The currency markets reacted well to the figures with the pound gaining nearly a cent against the dollar after their release.